Currently, medications used to treat rheumatoid arthritis (RA) are glucocorticoids (GCs) and
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …

Three important factors, including genetics, environment factors and autoimmunity play a
role in the pathogenesis of rheumatoid arthritis (RA). The heritability of RA has been …

Monocyte homing to the liver and adhesion to the liver sinusoidal endothelial cells (LSECs)
are key elements in nonalcoholic steatohepatitis (NASH) pathogenesis. We reported …

Cardiometabolic comorbidities present a considerable burden for patients with rheumatoid
arthritis (RA) or psoriatic arthritis (PsA). Both RA and PsA are associated with an increased …

Rheumatoid arthritis (RA) is a chronic inflammatory disease that mainly affects the joints,
though a consistent proportion of patients may also display extra articular manifestations …

Background: Rheumatoid arthritis (RA)-related comorbidities, including cardiovascular
disease (CVD), osteoporosis (OP), and interstitial lung disease (ILD), are sub-optimally …

Autoimmune rheumatic diseases (AIRDs) with unknown etiology are increasing in incidence
and prevalence. Up to 5% of the population is affected. AIRDs include rheumatoid arthritis …

Meteorin-like (Metrnl) is a newly discovered adipokine with favorable effect on insulin
sensitivity. Previous studies have reported lower levels of Metrnl in obese patients. However …

High mobility group box-1 (HMGB1) protein is a diverse, single polypeptide moiety, present
in mammalian eukaryotic cells. In response to stimuli, this nuclear protein is actively …

Coronary artery disease (CAD) is the leading cause of death worldwide. Atherosclerosis as
the main underlying mechanism of CAD is associated with inflammation and adipose tissue …